Shanghai Junshi Biosciences (SHJBF) News Today C$1.97 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Shanghai Junshi Biosciences Chairman to Boost Shareholding Amid New AgreementsApril 11, 2025 | tipranks.comShanghai Junshi Biosciences Schedules Board Meeting for Q1 Financial ReviewApril 10, 2025 | tipranks.comShanghai Junshi Biosciences Gains Approval for Toripalimab in SingaporeMarch 26, 2025 | tipranks.comJunshi Biosciences Gains Approval for New HCC TreatmentMarch 21, 2025 | tipranks.comShanghai Junshi Biosciences Gains Approval for Clinical Trials of JS212March 20, 2025 | tipranks.comShanghai Junshi Biosciences Announces Upcoming Board Meeting for Year-End ResultsMarch 15, 2025 | msn.comShanghai Junshi Biosciences Receives Approval for Clinical Trials of Innovative Cancer TherapyFebruary 5, 2025 | tipranks.comJunshi partners LEO Pharma for toripalimab distribution in EuropeJanuary 22, 2025 | msn.comShanghai Junshi Biosciences Partners with LEO Pharma for European ExpansionJanuary 20, 2025 | tipranks.comShanghai Junshi’s Toripalimab Gains TGA Approval for NPC TreatmentJanuary 17, 2025 | tipranks.comShanghai Junshi Biosciences Sees Revenue Growth Amid Reduced Losses in 2024January 17, 2025 | tipranks.comShanghai Junshi Biosciences Receives Regular Approval for COVID-19 DrugJanuary 10, 2025 | tipranks.comShanghai Junshi’s JS212 Drug Application Accepted, Boosting Cancer Therapy PipelineJanuary 8, 2025 | tipranks.comJunshi Biosciences’ Toripalimab Gains Regular Approval for Melanoma TreatmentJanuary 6, 2025 | tipranks.comShanghai Junshi Biosciences Proposes New Board MembersNovember 29, 2024 | tipranks.comShanghai Junshi Unveils Strategic Financial DecisionsNovember 29, 2024 | tipranks.comShanghai Junshi Biosciences Relocates Key OfficesNovember 29, 2024 | tipranks.comShanghai Junshi Biosciences’ TUOYI Gains Key Insurance InclusionNovember 28, 2024 | tipranks.comShanghai A Share IndexNovember 6, 2024 | marketwatch.comJunshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China’s Hong Kong SAROctober 16, 2024 | markets.businessinsider.comJunshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China's Hong Kong SAROctober 15, 2024 | tmcnet.comJunshi Biosciences Announces Positive Opinion from the European Medicines Agency’s CHMP For ToripalimabJuly 27, 2024 | markets.businessinsider.comWatch: Explore ShanghaiJuly 25, 2024 | bbc.co.ukShanghai Junshi Biosciences Co. Ltd.April 26, 2024 | wsj.comJunshi Biosciences Announces NDA Acceptance in Hong Kong for ToripalimabApril 24, 2024 | finance.yahoo.comJunshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences AuthorityFebruary 2, 2024 | finance.yahoo.comJunshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung CancerJanuary 18, 2024 | finance.yahoo.comShanghai Junshi Biosciences Co Ltd (1877)January 11, 2024 | investing.comJunshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature MedicineJanuary 10, 2024 | finance.yahoo.comShanghai LujianziJanuary 6, 2024 | forbes.comWhat to Eat in ShanghaiJanuary 5, 2024 | travel.usnews.comInovio stock surges to seven-month highJanuary 5, 2024 | msn.comJunshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC PatientsJanuary 2, 2024 | finance.yahoo.comHow long will Shanghai's lockdown last?December 12, 2023 | bbc.comWeek In Review: Tang Capital Offers $465M For LianBio Plus 80% Of Any Licenses/DivestmentsDecember 3, 2023 | seekingalpha.comJunshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGADecember 1, 2023 | finance.yahoo.comCoherus cancer drug undercuts Merck's KeytrudaNovember 28, 2023 | msn.comJunshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19November 22, 2023 | finance.yahoo.comCoherus, Shanghai Junshi Shares Gain After U.S. Approval For Nasopharyngeal Cancer DrugOctober 31, 2023 | msn.comJunshi-Coherus' Loqtorzi cancer drug wins FDA approvalOctober 30, 2023 | msn.comJunshi Biosciences Presents 11 Clinical Trials of Toripalimab at the ESMO Congress 2023October 27, 2023 | finance.yahoo.comJunshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as the First-line Treatment of Extensive-stage Small Cell Lung CancerJuly 19, 2023 | finance.yahoo.comShanghai Junshi Biosciences Co Ltd Class HJuly 15, 2023 | morningstar.comJunshi Biosciences Announces Acceptance of the Supplemental New Drug Application for ToripalimabJuly 11, 2023 | finance.yahoo.comShanghai OPM Biosciences Co. Ltd. AJune 19, 2023 | wsj.comJunshi's toripalimab gets Chinese regulator review for expanded use in breast cancerMay 23, 2023 | seekingalpha.comJunshi Biosciences Announces Acceptance of the Supplemental NDA for Toripalimab in Combination with Chemotherapy for Advanced Triple-negative Breast CancerMay 23, 2023 | finance.yahoo.comShanghai OPM Biosciences Co Ltd (688293)May 18, 2023 | investing.comShanghai Junshi Biosciences Co Ltd (688180)May 11, 2023 | investing.comJunshi Biosciences Announces Collaboration with Dr. Reddy's to Develop and Commercialize Toripalimab in 21 CountriesMay 7, 2023 | tmcnet.com Get Shanghai Junshi Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SHJBF and its competitors with MarketBeat's FREE daily newsletter. Email Address SHJBF Media Mentions By Week SHJBF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHJBF News Sentiment▼-1.000.59▲Average Medical News Sentiment SHJBF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHJBF Articles This Week▼00▲SHJBF Articles Average Week Get Shanghai Junshi Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SHJBF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Ascentage Pharma Group International News Ascletis Pharma News Avacta Group News Awakn Life Sciences News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHJBF) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Junshi Biosciences Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Junshi Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SHJBF Stock Free SHJBF Stock Alerts